Literature DB >> 21353349

Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.

Bakr F Abdel-Wahab1, Ghada E A Awad, Farid A Badria.   

Abstract

In the present work, 1-(5-methyl-2-phenyl-1H-imidazol-4-yl)ethanone 1 was prepared and used as a precursor for the synthesis of new thiazole, arylidiene and coumarin derivatives. The antimicrobial, antioxidant, anti-hemolytic, and cytotoxic activities of new compounds have been screened. Compound 12 showed an excellent antibacterial activity for all the tested bacteria with minimal inhibitory concentration (MIC) ranged between 21.9 and 43.8 μg/mL. While, compounds 2, 8 and 10a were the best antioxidant reagents using the DPPH method. Compounds 6a and 10b proved to exhibit potent antioxidative activity as reflected in the ability to inhibit lipid per-oxidation in rat brain and kidney homogenates and rate erythrocyte hemolysis. Compounds 6a proved to have the highest cytotoxic activity (81.9%) followed by 2, 6c, 7b and 12 using in vitro Ehrlich ascites assay. The details synthetic methods, spectroscopic data and biological results are recorded.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353349     DOI: 10.1016/j.ejmech.2011.01.062

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

Review 1.  Recent advances in the application of indoles in multicomponent reactions.

Authors:  Ghodsi Mohammadi Ziarani; Razieh Moradi; Tahereh Ahmadi; Negar Lashgari
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

2.  New Metallophthalocyanines Bearing 2-Methylimidazole Moieties-Potential Photosensitizers against Staphylococcus aureus.

Authors:  Marcin Wierzchowski; Daniel Ziental; Dawid Łażewski; Artur Korzanski; Agnieszka Gielara-Korzanska; Ewa Tykarska; Jolanta Dlugaszewska; Lukasz Sobotta
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

3.  New benzenesulphonohydrazide derivatives as potential antitumour agents.

Authors:  Łukasz Popiołek; Monika Gawrońska-Grzywacz; Anna Berecka-Rycerz; Kinga Paruch; Iwona Piątkowska-Chmiel; Dorota Natorska-Chomicka; Mariola Herbet; Anna Gumieniczek; Jarosław Dudka; Monika Wujec
Journal:  Oncol Lett       Date:  2020-09-02       Impact factor: 2.967

Review 4.  An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety.

Authors:  Renzo Rossi; Maurizio Ciofalo
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

5.  Synthesis, characterization, molecular docking studies and biological evaluation of some novel hybrids based on quinazolinone, benzofuran and imidazolium moieties as potential cytotoxic and antimicrobial agents.

Authors:  Parvin Asadi; Ghadamali Khodarahmi; Ali Jahanian-Najafabadi; Lotfollah Saghaie; Farshid Hassanzadeh
Journal:  Iran J Basic Med Sci       Date:  2017-09       Impact factor: 2.699

6.  Quantum mechanical/molecular mechanical and docking study of the novel analogues based on hybridization of common pharmacophores as potential anti-breast cancer agents.

Authors:  Parvin Asadi; Ghadamali Khodarahmi; Hossein Farrokhpour; Farshid Hassanzadeh; Lotfollah Saghaei
Journal:  Res Pharm Sci       Date:  2017-06

7.  Coordination Behavior of Ni2+, Cu2+, and Zn2+ in Tetrahedral 1-Methylimidazole Complexes: A DFT/CSD Study.

Authors:  Samuel Tetteh
Journal:  Bioinorg Chem Appl       Date:  2018-05-14       Impact factor: 7.778

Review 8.  Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.

Authors:  Dmytro Havrylyuk; Olexandra Roman; Roman Lesyk
Journal:  Eur J Med Chem       Date:  2016-02-16       Impact factor: 6.514

Review 9.  A review exploring biological activities of hydrazones.

Authors:  Garima Verma; Akranth Marella; Mohammad Shaquiquzzaman; Mymoona Akhtar; Mohammad Rahmat Ali; Mohammad Mumtaz Alam
Journal:  J Pharm Bioallied Sci       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.